{"transactions":[{"id":1080846,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2025-07-28T10:18:12.000Z","date":"2025-07-24","kind":"grant","planned":false,"acquired":true,"shares":3650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual non-employee director award."}],"balance_after":3650,"derivative":{"exercise_price":306.41,"exercise_date":"2026-07-09","expiration_date":"2035-07-24","underlying":"Common Stock","underlying_shares":3650},"source":{"system":"sec-edgar","filing":"0001562180-25-005523","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218025005523/primarydocument.xml","form_type":"4"}},{"id":1167902,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-04-22T20:30:26.000Z","date":"2025-04-21","kind":"exercise","planned":true,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 2, 2024."}],"balance_after":0,"derivative":{"exercise_price":175.43,"exercise_date":"2016-06-26","expiration_date":"2025-06-26","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001562180-25-003225","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218025003225/primarydocument.xml","form_type":"4"}},{"id":1167901,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-22T20:30:26.000Z","date":"2025-04-21","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":285.57,"value":856710.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 2, 2024."}],"balance_after":1750,"source":{"system":"sec-edgar","filing":"0001562180-25-003225","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218025003225/primarydocument.xml","form_type":"4"}},{"id":1167900,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-22T20:30:26.000Z","date":"2025-04-21","kind":"exercise","planned":true,"acquired":true,"shares":3000,"price":175.43,"value":526290.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 2, 2024."}],"balance_after":4750,"source":{"system":"sec-edgar","filing":"0001562180-25-003225","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218025003225/primarydocument.xml","form_type":"4"}},{"id":1172123,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-04-15T20:28:11.000Z","date":"2025-04-14","kind":"exercise","planned":true,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 2, 2024."}],"balance_after":3000,"derivative":{"exercise_price":175.43,"exercise_date":"2016-06-26","expiration_date":"2025-06-26","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001562180-25-003157","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218025003157/primarydocument.xml","form_type":"4"}},{"id":1172122,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-15T20:28:11.000Z","date":"2025-04-14","kind":"sale","planned":true,"acquired":false,"shares":3000,"price":285.16,"value":855480.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 2, 2024."}],"balance_after":1750,"source":{"system":"sec-edgar","filing":"0001562180-25-003157","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218025003157/primarydocument.xml","form_type":"4"}},{"id":1172121,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-15T20:28:11.000Z","date":"2025-04-14","kind":"exercise","planned":true,"acquired":true,"shares":3000,"price":175.43,"value":526290.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 2, 2024."}],"balance_after":4750,"source":{"system":"sec-edgar","filing":"0001562180-25-003157","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218025003157/primarydocument.xml","form_type":"4"}},{"id":1175974,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-04-08T20:30:40.000Z","date":"2025-04-07","kind":"exercise","planned":true,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 2, 2024."}],"balance_after":6000,"derivative":{"exercise_price":175.43,"exercise_date":"2016-06-26","expiration_date":"2025-06-26","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001562180-25-003069","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218025003069/primarydocument.xml","form_type":"4"}},{"id":1175973,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-08T20:30:40.000Z","date":"2025-04-07","kind":"sale","planned":true,"acquired":false,"shares":4000,"price":284.55,"value":1138200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 2, 2024."}],"balance_after":1750,"source":{"system":"sec-edgar","filing":"0001562180-25-003069","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218025003069/primarydocument.xml","form_type":"4"}},{"id":1175972,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-08T20:30:40.000Z","date":"2025-04-07","kind":"exercise","planned":true,"acquired":true,"shares":4000,"price":175.43,"value":701720.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on August 2, 2024."}],"balance_after":5750,"source":{"system":"sec-edgar","filing":"0001562180-25-003069","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000156218025003069/primarydocument.xml","form_type":"4"}},{"id":1441285,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-08-05T20:30:07.000Z","date":"2024-08-02","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10000,"derivative":{"exercise_price":175.43,"exercise_date":"2016-06-26","expiration_date":"2025-06-26","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001415889-24-020750","document":"form4-08052024_040801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588924020750/form4-08052024_040801.xml","form_type":"4"}},{"id":1441284,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-05T20:30:07.000Z","date":"2024-08-02","kind":"sale","planned":false,"acquired":false,"shares":100,"price":330.39,"value":33039.0,"ownership":{"direct":true},"balance_after":1750,"source":{"system":"sec-edgar","filing":"0001415889-24-020750","document":"form4-08052024_040801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588924020750/form4-08052024_040801.xml","form_type":"4"}},{"id":1441283,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-05T20:30:07.000Z","date":"2024-08-02","kind":"sale","planned":false,"acquired":false,"shares":900,"price":328.9878,"value":296089.02,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $328.54 to $329.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":1850,"source":{"system":"sec-edgar","filing":"0001415889-24-020750","document":"form4-08052024_040801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588924020750/form4-08052024_040801.xml","form_type":"4"}},{"id":1441282,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-05T20:30:07.000Z","date":"2024-08-02","kind":"sale","planned":false,"acquired":false,"shares":1300,"price":327.955,"value":426341.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $327.505 to $328.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":2750,"source":{"system":"sec-edgar","filing":"0001415889-24-020750","document":"form4-08052024_040801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588924020750/form4-08052024_040801.xml","form_type":"4"}},{"id":1441281,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-05T20:30:07.000Z","date":"2024-08-02","kind":"sale","planned":false,"acquired":false,"shares":900,"price":326.3972,"value":293757.48,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $325.98 to $326.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":4050,"source":{"system":"sec-edgar","filing":"0001415889-24-020750","document":"form4-08052024_040801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588924020750/form4-08052024_040801.xml","form_type":"4"}},{"id":1441280,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-05T20:30:07.000Z","date":"2024-08-02","kind":"sale","planned":false,"acquired":false,"shares":900,"price":321.2867,"value":289158.03,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $321.14 to $321.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":4950,"source":{"system":"sec-edgar","filing":"0001415889-24-020750","document":"form4-08052024_040801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588924020750/form4-08052024_040801.xml","form_type":"4"}},{"id":1441279,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-05T20:30:07.000Z","date":"2024-08-02","kind":"sale","planned":false,"acquired":false,"shares":900,"price":320.3883,"value":288349.47,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $320.04 to $320.8924. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":5850,"source":{"system":"sec-edgar","filing":"0001415889-24-020750","document":"form4-08052024_040801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588924020750/form4-08052024_040801.xml","form_type":"4"}},{"id":1441278,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-05T20:30:07.000Z","date":"2024-08-02","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":175.43,"value":877150.0,"ownership":{"direct":true},"balance_after":6750,"source":{"system":"sec-edgar","filing":"0001415889-24-020750","document":"form4-08052024_040801.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588924020750/form4-08052024_040801.xml","form_type":"4"}},{"id":1448242,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2024-07-26T20:30:07.000Z","date":"2024-07-25","kind":"grant","planned":false,"acquired":true,"shares":2890,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual non-employee director award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These awards vest on the one-year anniversary of the grant date."}],"balance_after":2890,"derivative":{"exercise_price":336.37,"exercise_date":"2025-07-25","expiration_date":"2034-07-25","underlying":"Common Stock","underlying_shares":2890},"source":{"system":"sec-edgar","filing":"0001415889-24-020163","document":"form4-07262024_040703.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588924020163/form4-07262024_040703.xml","form_type":"4"}},{"id":1537074,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Tracking Award","published_at":"2024-04-23T20:30:31.000Z","date":"2024-04-22","kind":"exercise","planned":true,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on November 27, 2023. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":0,"derivative":{"exercise_price":88.03,"exercise_date":"2015-06-26","expiration_date":"2024-06-26","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001415889-24-011371","document":"form4-04232024_040404.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588924011371/form4-04232024_040404.xml","form_type":"4"}},{"id":1537073,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-23T20:30:31.000Z","date":"2024-04-22","kind":"disposition_to_issuer","planned":true,"acquired":false,"shares":3000,"price":234.06,"value":702180.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on November 27, 2023. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":1750,"source":{"system":"sec-edgar","filing":"0001415889-24-011371","document":"form4-04232024_040404.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588924011371/form4-04232024_040404.xml","form_type":"4"}},{"id":1537072,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-23T20:30:31.000Z","date":"2024-04-22","kind":"exercise","planned":true,"acquired":true,"shares":3000,"price":88.03,"value":264090.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on November 27, 2023. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":4750,"source":{"system":"sec-edgar","filing":"0001415889-24-011371","document":"form4-04232024_040404.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588924011371/form4-04232024_040404.xml","form_type":"4"}},{"id":1541487,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Tracking Award","published_at":"2024-04-16T20:30:20.000Z","date":"2024-04-15","kind":"exercise","planned":true,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on November 27, 2023. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":3000,"derivative":{"exercise_price":88.03,"exercise_date":"2015-06-26","expiration_date":"2024-06-26","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001415889-24-010867","document":"form4-04162024_040409.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588924010867/form4-04162024_040409.xml","form_type":"4"}},{"id":1541486,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-16T20:30:20.000Z","date":"2024-04-15","kind":"disposition_to_issuer","planned":true,"acquired":false,"shares":3000,"price":235.08,"value":705240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on November 27, 2023. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":1750,"source":{"system":"sec-edgar","filing":"0001415889-24-010867","document":"form4-04162024_040409.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588924010867/form4-04162024_040409.xml","form_type":"4"}},{"id":1541485,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-16T20:30:20.000Z","date":"2024-04-15","kind":"exercise","planned":true,"acquired":true,"shares":3000,"price":88.03,"value":264090.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on November 27, 2023. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":4750,"source":{"system":"sec-edgar","filing":"0001415889-24-010867","document":"form4-04162024_040409.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588924010867/form4-04162024_040409.xml","form_type":"4"}},{"id":1544812,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Tracking Award","published_at":"2024-04-09T20:30:19.000Z","date":"2024-04-08","kind":"exercise","planned":true,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on November 27, 2023. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":6000,"derivative":{"exercise_price":88.03,"exercise_date":"2015-06-26","expiration_date":"2024-06-26","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001415889-24-010572","document":"form4-04092024_040405.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588924010572/form4-04092024_040405.xml","form_type":"4"}},{"id":1544811,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-09T20:30:19.000Z","date":"2024-04-08","kind":"disposition_to_issuer","planned":true,"acquired":false,"shares":4000,"price":236.96,"value":947840.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on November 27, 2023. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":1750,"source":{"system":"sec-edgar","filing":"0001415889-24-010572","document":"form4-04092024_040405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588924010572/form4-04092024_040405.xml","form_type":"4"}},{"id":1544810,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-09T20:30:19.000Z","date":"2024-04-08","kind":"exercise","planned":true,"acquired":true,"shares":4000,"price":88.03,"value":352120.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person on November 27, 2023. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":5750,"source":{"system":"sec-edgar","filing":"0001415889-24-010572","document":"form4-04092024_040405.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588924010572/form4-04092024_040405.xml","form_type":"4"}},{"id":1828969,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2023-07-17T10:30:20.000Z","date":"2023-07-13","kind":"grant","planned":false,"acquired":true,"shares":4560,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Annual non-employee director award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These awards vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders."}],"balance_after":4560,"derivative":{"exercise_price":229.81,"exercise_date":"2024-07-13","expiration_date":"2033-07-13","underlying":"Common Stock","underlying_shares":4560},"source":{"system":"sec-edgar","filing":"0001415889-23-011155","document":"form4-07172023_060716.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588923011155/form4-07172023_060716.xml","form_type":"4"}},{"id":1833162,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-07-07T20:30:11.000Z","date":"2023-07-07","kind":"exercise","planned":false,"acquired":false,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Shares received upon vesting of restricted stock units on July 7, 2023. Restricted stock units converted on a one-for-one basis into shares of common stock."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received upon vesting of restricted stock units on July 7, 2023. Restricted stock units converted on a one-for-one basis into shares of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Not applicable as restricted stock units do not have an expiration date."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2023-07-07","underlying":"Common Stock","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001415889-23-010946","document":"form4-07072023_040703.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588923010946/form4-07072023_040703.xml","form_type":"4"}},{"id":1833161,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-07T20:30:11.000Z","date":"2023-07-07","kind":"exercise","planned":false,"acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares received upon vesting of restricted stock units on July 7, 2023. Restricted stock units converted on a one-for-one basis into shares of common stock."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares received upon vesting of restricted stock units on July 7, 2023. Restricted stock units converted on a one-for-one basis into shares of common stock."}],"balance_after":1750,"source":{"system":"sec-edgar","filing":"0001415889-23-010946","document":"form4-07072023_040703.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588923010946/form4-07072023_040703.xml","form_type":"4"}},{"id":1915070,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Tracking Award","published_at":"2023-04-24T20:30:18.000Z","date":"2023-04-21","kind":"exercise","planned":false,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":0,"derivative":{"exercise_price":63.9,"exercise_date":"2014-06-26","expiration_date":"2023-06-26","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001415889-23-006806","document":"form4-04242023_040404.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588923006806/form4-04242023_040404.xml","form_type":"4"}},{"id":1915069,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-24T20:30:18.000Z","date":"2023-04-21","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2000,"price":230.76,"value":461520.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-23-006806","document":"form4-04242023_040404.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588923006806/form4-04242023_040404.xml","form_type":"4"}},{"id":1915068,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-24T20:30:18.000Z","date":"2023-04-21","kind":"exercise","planned":false,"acquired":true,"shares":2000,"price":63.9,"value":127800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001415889-23-006806","document":"form4-04242023_040404.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588923006806/form4-04242023_040404.xml","form_type":"4"}},{"id":1918389,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Tracking Award","published_at":"2023-04-18T20:30:17.000Z","date":"2023-04-14","kind":"exercise","planned":false,"acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":2000,"derivative":{"exercise_price":63.9,"exercise_date":"2014-06-26","expiration_date":"2023-06-26","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001415889-23-006615","document":"form4-04182023_040407.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588923006615/form4-04182023_040407.xml","form_type":"4"}},{"id":1918388,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-18T20:30:17.000Z","date":"2023-04-14","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2000,"price":228.72,"value":457440.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-23-006615","document":"form4-04182023_040407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588923006615/form4-04182023_040407.xml","form_type":"4"}},{"id":1918387,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-18T20:30:17.000Z","date":"2023-04-14","kind":"exercise","planned":false,"acquired":true,"shares":2000,"price":63.9,"value":127800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001415889-23-006615","document":"form4-04182023_040407.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588923006615/form4-04182023_040407.xml","form_type":"4"}},{"id":1921270,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Tracking Award","published_at":"2023-04-12T20:30:07.000Z","date":"2023-04-10","kind":"exercise","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":4000,"derivative":{"exercise_price":63.9,"exercise_date":"2014-06-26","expiration_date":"2023-06-26","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001415889-23-006472","document":"form4-04122023_040401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588923006472/form4-04122023_040401.xml","form_type":"4"}},{"id":1921269,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-12T20:30:07.000Z","date":"2023-04-10","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3000,"price":223.07,"value":669210.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-23-006472","document":"form4-04122023_040401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588923006472/form4-04122023_040401.xml","form_type":"4"}},{"id":1921268,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-12T20:30:07.000Z","date":"2023-04-10","kind":"exercise","planned":false,"acquired":true,"shares":3000,"price":63.9,"value":191700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001415889-23-006472","document":"form4-04122023_040401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588923006472/form4-04122023_040401.xml","form_type":"4"}},{"id":2122576,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Tracking Award","published_at":"2022-11-08T21:30:17.000Z","date":"2022-11-07","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Share tracking awards are non-dilutive, cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":10000,"derivative":{"exercise_price":88.03,"exercise_date":"2015-06-26","expiration_date":"2024-06-26","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001415889-22-011178","document":"form4-11082022_041101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922011178/form4-11082022_041101.xml","form_type":"4"}},{"id":2122575,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-08T21:30:17.000Z","date":"2022-11-07","kind":"disposition_to_issuer","acquired":false,"shares":5000,"price":266.8,"value":1334000.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-22-011178","document":"form4-11082022_041101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922011178/form4-11082022_041101.xml","form_type":"4"}},{"id":2122574,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-08T21:30:17.000Z","date":"2022-11-07","kind":"exercise","acquired":true,"shares":5000,"price":88.03,"value":440150.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001415889-22-011178","document":"form4-11082022_041101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922011178/form4-11082022_041101.xml","form_type":"4"}},{"id":2161566,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Tracking Award","published_at":"2022-09-12T20:30:15.000Z","date":"2022-09-09","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Share tracking awards are non-dilutive, cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":7000,"derivative":{"exercise_price":63.9,"exercise_date":"2014-06-26","expiration_date":"2023-06-26","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001415889-22-009534","document":"form4-09122022_040901.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922009534/form4-09122022_040901.xml","form_type":"4"}},{"id":2161565,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-12T20:30:15.000Z","date":"2022-09-09","kind":"disposition_to_issuer","acquired":false,"shares":3000,"price":223.48,"value":670440.0,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-22-009534","document":"form4-09122022_040901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922009534/form4-09122022_040901.xml","form_type":"4"}},{"id":2161564,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-12T20:30:15.000Z","date":"2022-09-09","kind":"exercise","acquired":true,"shares":3000,"price":63.9,"value":191700.0,"ownership":{"direct":true},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001415889-22-009534","document":"form4-09122022_040901.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922009534/form4-09122022_040901.xml","form_type":"4"}},{"id":2209313,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-07-11T20:30:20.000Z","date":"2022-07-07","kind":"grant","acquired":true,"shares":1750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock."},{"field":"shares","element":"transactionShares","label":"F5","text":"Annual non-employee director award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders."}],"balance_after":1750,"derivative":{"exercise_price":0,"exercise_date":"2023-07-07","underlying":"Common Stock","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001415889-22-007625","document":"form4-07112022_040701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922007625/form4-07112022_040701.xml","form_type":"4"}},{"id":2209312,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-07-11T20:30:20.000Z","date":"2022-07-08","kind":"exercise","acquired":false,"shares":2160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2022-07-08","underlying":"Common Stock","underlying_shares":2160},"source":{"system":"sec-edgar","filing":"0001415889-22-007625","document":"form4-07112022_040701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922007625/form4-07112022_040701.xml","form_type":"4"}},{"id":2209311,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-11T20:30:20.000Z","date":"2022-07-11","kind":"sale","acquired":false,"shares":2160,"price":241.29,"value":521186.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"This sale of common stock was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-22-007625","document":"form4-07112022_040701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922007625/form4-07112022_040701.xml","form_type":"4"}},{"id":2209310,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-11T20:30:20.000Z","date":"2022-07-08","kind":"exercise","acquired":true,"shares":2160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares received upon vesting of restricted stock units on July 8, 2022. Restricted stock units converted on a one-for-one basis into shares of common stock."}],"balance_after":2160,"source":{"system":"sec-edgar","filing":"0001415889-22-007625","document":"form4-07112022_040701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922007625/form4-07112022_040701.xml","form_type":"4"}},{"id":2255690,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Tracking Award","published_at":"2022-05-26T23:01:40.000Z","date":"2022-05-26","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Share tracking awards are non-dilutive, cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":10000,"derivative":{"exercise_price":63.9,"exercise_date":"2014-06-26","expiration_date":"2023-06-26","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001415889-22-005734","document":"form4-05262022_040525.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922005734/form4-05262022_040525.xml","form_type":"4"}},{"id":2255689,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-26T23:01:40.000Z","date":"2022-05-26","kind":"disposition_to_issuer","acquired":false,"shares":5000,"price":224.78,"value":1123900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of share tracking awards. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001415889-22-005734","document":"form4-05262022_040525.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922005734/form4-05262022_040525.xml","form_type":"4"}},{"id":2255688,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-26T23:01:40.000Z","date":"2022-05-26","kind":"exercise","acquired":true,"shares":5000,"price":63.9,"value":319500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This is an exercise of share tracking awards. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":7000,"source":{"system":"sec-edgar","filing":"0001415889-22-005734","document":"form4-05262022_040525.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922005734/form4-05262022_040525.xml","form_type":"4"}},{"id":2279661,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Tracking Award","published_at":"2022-05-06T20:30:18.000Z","date":"2022-05-05","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":0,"derivative":{"exercise_price":48.11,"exercise_date":"2013-06-26","expiration_date":"2022-06-26","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001415889-22-004706","document":"form4-05062022_040501.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922004706/form4-05062022_040501.xml","form_type":"4"}},{"id":2279660,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-06T20:30:18.000Z","date":"2022-05-05","kind":"disposition_to_issuer","acquired":false,"shares":2000,"price":186.99,"value":373980.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-22-004706","document":"form4-05062022_040501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922004706/form4-05062022_040501.xml","form_type":"4"}},{"id":2279659,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-05-06T20:30:18.000Z","date":"2022-05-05","kind":"exercise","acquired":true,"shares":2000,"price":48.11,"value":96220.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001415889-22-004706","document":"form4-05062022_040501.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922004706/form4-05062022_040501.xml","form_type":"4"}},{"id":2288124,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Tracking Award","published_at":"2022-04-29T20:30:51.000Z","date":"2022-04-28","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":2000,"derivative":{"exercise_price":48.11,"exercise_date":"2013-06-26","expiration_date":"2022-06-26","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001415889-22-004365","document":"form4-04292022_040401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922004365/form4-04292022_040401.xml","form_type":"4"}},{"id":2288123,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-29T20:30:51.000Z","date":"2022-04-28","kind":"disposition_to_issuer","acquired":false,"shares":2000,"price":179.34,"value":358680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-22-004365","document":"form4-04292022_040401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922004365/form4-04292022_040401.xml","form_type":"4"}},{"id":2288122,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-29T20:30:51.000Z","date":"2022-04-28","kind":"exercise","acquired":true,"shares":2000,"price":48.11,"value":96220.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001415889-22-004365","document":"form4-04292022_040401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922004365/form4-04292022_040401.xml","form_type":"4"}},{"id":2292071,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Tracking Award","published_at":"2022-04-22T20:30:25.000Z","date":"2022-04-21","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":4000,"derivative":{"exercise_price":48.11,"exercise_date":"2013-06-26","expiration_date":"2022-06-26","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001415889-22-004229","document":"form4-04222022_040402.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922004229/form4-04222022_040402.xml","form_type":"4"}},{"id":2292070,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-22T20:30:25.000Z","date":"2022-04-21","kind":"disposition_to_issuer","acquired":false,"shares":2000,"price":190.22,"value":380440.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-22-004229","document":"form4-04222022_040402.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922004229/form4-04222022_040402.xml","form_type":"4"}},{"id":2292069,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-22T20:30:25.000Z","date":"2022-04-21","kind":"exercise","acquired":true,"shares":2000,"price":48.11,"value":96220.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001415889-22-004229","document":"form4-04222022_040402.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922004229/form4-04222022_040402.xml","form_type":"4"}},{"id":2296595,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Tracking Award","published_at":"2022-04-15T20:30:34.000Z","date":"2022-04-14","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":6000,"derivative":{"exercise_price":48.11,"exercise_date":"2013-06-26","expiration_date":"2022-06-26","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001415889-22-004084","document":"form4-04152022_040401.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922004084/form4-04152022_040401.xml","form_type":"4"}},{"id":2296594,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-15T20:30:34.000Z","date":"2022-04-14","kind":"disposition_to_issuer","acquired":false,"shares":2000,"price":191.91,"value":383820.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-22-004084","document":"form4-04152022_040401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922004084/form4-04152022_040401.xml","form_type":"4"}},{"id":2296593,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-15T20:30:34.000Z","date":"2022-04-14","kind":"exercise","acquired":true,"shares":2000,"price":48.11,"value":96220.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001415889-22-004084","document":"form4-04152022_040401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922004084/form4-04152022_040401.xml","form_type":"4"}},{"id":2300592,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Share Tracking Award","published_at":"2022-04-08T20:30:26.000Z","date":"2022-04-07","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":8000,"derivative":{"exercise_price":48.11,"exercise_date":"2013-06-26","expiration_date":"2022-06-26","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001415889-22-003959","document":"form4-04082022_040411.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922003959/form4-04082022_040411.xml","form_type":"4"}},{"id":2300591,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-08T20:30:26.000Z","date":"2022-04-07","kind":"disposition_to_issuer","acquired":false,"shares":2000,"price":190.11,"value":380220.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-22-003959","document":"form4-04082022_040411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922003959/form4-04082022_040411.xml","form_type":"4"}},{"id":2300590,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-04-08T20:30:26.000Z","date":"2022-04-07","kind":"exercise","acquired":true,"shares":2000,"price":48.11,"value":96220.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001415889-22-003959","document":"form4-04082022_040411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000141588922003959/form4-04082022_040411.xml","form_type":"4"}},{"id":2521833,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true}}],"security":"Share Tracking Award","published_at":"2021-11-08T23:51:07.000Z","date":"2021-11-08","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":10000,"derivative":{"exercise_price":48.11,"exercise_date":"2013-06-26","expiration_date":"2022-06-26","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001127602-21-028625","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760221028625/form4.xml","form_type":"4"}},{"id":2521832,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-11-08T23:51:07.000Z","date":"2021-11-08","kind":"disposition_to_issuer","acquired":false,"shares":3000,"price":202.09,"value":606270.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-21-028625","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760221028625/form4.xml","form_type":"4"}},{"id":2521831,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-11-08T23:51:07.000Z","date":"2021-11-08","kind":"exercise","acquired":true,"shares":3000,"price":48.11,"value":144330.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":3000,"source":{"system":"sec-edgar","filing":"0001127602-21-028625","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760221028625/form4.xml","form_type":"4"}},{"id":2637246,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2021-07-09T20:50:48.000Z","date":"2021-07-08","kind":"grant","acquired":true,"shares":2160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Annual non-employee director grant of restricted stock units, which are awarded each year on the date of the first board meeting following the issuer's Annual Meeting of Shareholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders."}],"balance_after":2160,"derivative":{"exercise_price":0,"exercise_date":"2022-07-08","underlying":"Common Stock","underlying_shares":2160},"source":{"system":"sec-edgar","filing":"0001127602-21-021759","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760221021759/form4.xml","form_type":"4"}},{"id":2650666,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-06-30T20:32:15.000Z","date":"2021-06-29","kind":"sale","acquired":false,"shares":3360,"price":176.01,"value":591393.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale of common stock was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-21-020861","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760221020861/form4.xml","form_type":"4"}},{"id":2652384,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2021-06-29T20:34:50.000Z","date":"2021-06-26","kind":"exercise","acquired":false,"shares":3360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Award becomes fully vested on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2021-06-26","underlying":"Common Stock","underlying_shares":3360},"source":{"system":"sec-edgar","filing":"0001127602-21-020803","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760221020803/form4.xml","form_type":"4"}},{"id":2652383,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-06-29T20:34:50.000Z","date":"2021-06-26","kind":"exercise","acquired":true,"shares":3360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares received upon vesting of restricted stock units on June 26, 2021. Restricted stock units converted on a one-for-one basis into shares of common stock."}],"balance_after":3360,"source":{"system":"sec-edgar","filing":"0001127602-21-020803","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760221020803/form4.xml","form_type":"4"}},{"id":2725417,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true}}],"security":"Share Tracking Award","published_at":"2021-05-06T20:40:20.000Z","date":"2021-05-05","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. These awards were granted June 29, 2011 and were set to expire June 29, 2021."}],"balance_after":0,"derivative":{"exercise_price":54.77,"exercise_date":"2012-06-29","expiration_date":"2021-06-29","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001127602-21-015745","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760221015745/form4.xml","form_type":"4"}},{"id":2725416,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-05-06T20:40:20.000Z","date":"2021-05-05","kind":"disposition_to_issuer","acquired":false,"shares":2000,"price":198.14,"value":396280.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. These awards were granted June 29, 2011 and were set to expire June 29, 2021."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-21-015745","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760221015745/form4.xml","form_type":"4"}},{"id":2725415,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-05-06T20:40:20.000Z","date":"2021-05-05","kind":"exercise","acquired":true,"shares":2000,"price":54.77,"value":109540.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. These awards were granted June 29, 2011 and were set to expire June 29, 2021."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001127602-21-015745","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760221015745/form4.xml","form_type":"4"}},{"id":2736249,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true}}],"security":"Share Tracking Award","published_at":"2021-04-29T20:32:52.000Z","date":"2021-04-28","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. These awards were granted June 29, 2011 and were set to expire June 29, 2021."}],"balance_after":2000,"derivative":{"exercise_price":54.77,"exercise_date":"2012-06-29","expiration_date":"2021-06-29","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001127602-21-014699","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760221014699/form4.xml","form_type":"4"}},{"id":2736248,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-04-29T20:32:52.000Z","date":"2021-04-28","kind":"disposition_to_issuer","acquired":false,"shares":2000,"price":205.62,"value":411240.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. These awards were granted June 29, 2011 and were set to expire June 29, 2021."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-21-014699","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760221014699/form4.xml","form_type":"4"}},{"id":2736247,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-04-29T20:32:52.000Z","date":"2021-04-28","kind":"exercise","acquired":true,"shares":2000,"price":54.77,"value":109540.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. These awards were granted June 29, 2011 and were set to expire June 29, 2021."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001127602-21-014699","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760221014699/form4.xml","form_type":"4"}},{"id":2742286,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true}}],"security":"Share Tracking Award","published_at":"2021-04-22T20:31:33.000Z","date":"2021-04-21","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. These awards were granted June 29, 2011 and were set to expire June 29, 2021."}],"balance_after":4000,"derivative":{"exercise_price":54.77,"exercise_date":"2012-06-29","expiration_date":"2021-06-29","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001127602-21-014301","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760221014301/form4.xml","form_type":"4"}},{"id":2742285,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-04-22T20:31:33.000Z","date":"2021-04-21","kind":"disposition_to_issuer","acquired":false,"shares":2000,"price":211.93,"value":423860.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. These awards were granted June 29, 2011 and were set to expire June 29, 2021."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-21-014301","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760221014301/form4.xml","form_type":"4"}},{"id":2742284,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-04-22T20:31:33.000Z","date":"2021-04-21","kind":"exercise","acquired":true,"shares":2000,"price":54.77,"value":109540.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. These awards were granted June 29, 2011 and were set to expire June 29, 2021."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001127602-21-014301","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760221014301/form4.xml","form_type":"4"}},{"id":2748813,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true}}],"security":"Share Tracking Award","published_at":"2021-04-15T20:32:43.000Z","date":"2021-04-14","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. These awards were granted June 29, 2011 and were set to expire June 29, 2021."}],"balance_after":6000,"derivative":{"exercise_price":54.77,"exercise_date":"2012-06-29","expiration_date":"2021-06-29","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001127602-21-013748","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760221013748/form4.xml","form_type":"4"}},{"id":2748812,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-04-15T20:32:43.000Z","date":"2021-04-14","kind":"disposition_to_issuer","acquired":false,"shares":2000,"price":202.78,"value":405560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. These awards were granted June 29, 2011 and were set to expire June 29, 2021."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-21-013748","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760221013748/form4.xml","form_type":"4"}},{"id":2748811,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-04-15T20:32:43.000Z","date":"2021-04-14","kind":"exercise","acquired":true,"shares":2000,"price":54.77,"value":109540.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. These awards were granted June 29, 2011 and were set to expire June 29, 2021."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001127602-21-013748","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760221013748/form4.xml","form_type":"4"}},{"id":2753294,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true}}],"security":"Share Tracking Award","published_at":"2021-04-08T21:26:06.000Z","date":"2021-04-07","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. These awards were granted June 29, 2011 and were set to expire June 29, 2021."}],"balance_after":8000,"derivative":{"exercise_price":54.77,"exercise_date":"2012-06-29","expiration_date":"2021-06-29","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001127602-21-013489","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760221013489/form4.xml","form_type":"4"}},{"id":2753293,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-04-08T21:26:06.000Z","date":"2021-04-07","kind":"disposition_to_issuer","acquired":false,"shares":2000,"price":191.1,"value":382200.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. These awards were granted June 29, 2011 and were set to expire June 29, 2021."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-21-013489","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760221013489/form4.xml","form_type":"4"}},{"id":2753292,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-04-08T21:26:06.000Z","date":"2021-04-07","kind":"exercise","acquired":true,"shares":2000,"price":54.77,"value":109540.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise of share tracking awards was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. These awards were granted June 29, 2011 and were set to expire June 29, 2021."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001127602-21-013489","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760221013489/form4.xml","form_type":"4"}},{"id":2984478,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true}}],"security":"Share Tracking Award","published_at":"2020-11-12T21:33:01.000Z","date":"2020-11-10","kind":"exercise","acquired":false,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":13000,"derivative":{"exercise_price":48.11,"exercise_date":"2013-06-26","expiration_date":"2022-06-26","underlying":"Common Stock","underlying_shares":2000},"source":{"system":"sec-edgar","filing":"0001127602-20-028799","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760220028799/form4.xml","form_type":"4"}},{"id":2984477,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-11-12T21:33:01.000Z","date":"2020-11-10","kind":"disposition_to_issuer","acquired":false,"shares":2000,"price":139.28,"value":278560.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-20-028799","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760220028799/form4.xml","form_type":"4"}},{"id":2984476,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-11-12T21:33:01.000Z","date":"2020-11-10","kind":"exercise","acquired":true,"shares":2000,"price":48.11,"value":96220.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001127602-20-028799","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760220028799/form4.xml","form_type":"4"}},{"id":2995312,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true}}],"security":"Share Tracking Award","published_at":"2020-11-03T21:44:30.000Z","date":"2020-11-02","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":10000,"derivative":{"exercise_price":54.77,"exercise_date":"2012-06-29","expiration_date":"2021-06-29","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001127602-20-028033","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760220028033/form4.xml","form_type":"4"}},{"id":2995311,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-11-03T21:44:30.000Z","date":"2020-11-02","kind":"disposition_to_issuer","acquired":false,"shares":5000,"price":133.98,"value":669900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001127602-20-028033","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760220028033/form4.xml","form_type":"4"}},{"id":2995310,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-11-03T21:44:30.000Z","date":"2020-11-02","kind":"exercise","acquired":true,"shares":5000,"price":54.77,"value":273850.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Share tracking awards are non-dilutive cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001127602-20-028033","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000112760220028033/form4.xml","form_type":"4"}},{"id":3096980,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-06-30T17:56:27.000Z","date":"2020-06-26","kind":"grant","acquired":true,"shares":3360,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock."},{"field":"shares","element":"transactionShares","label":"F4","text":"Annual non-employee director grant of restricted stock units, which are awarded each year on the date of the issuer's Annual Meeting of Shareholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Shares will be issued to the reporting person upon vesting unless the reporting person has elected to defer receipt of shares."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"The restricted stock units vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders. Shares will be issued to the reporting person upon vesting unless the reporting person has elected to defer receipt of shares."}],"balance_after":3360,"derivative":{"exercise_price":0,"exercise_date":"2021-06-26","underlying":"Common Stock","underlying_shares":3360},"source":{"system":"sec-edgar","filing":"0001104659-20-078794","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000110465920078794/a4.xml","form_type":"4"}},{"id":3096979,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-06-30T17:56:27.000Z","date":"2020-06-26","kind":"exercise","acquired":false,"shares":4600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2020-06-26","expiration_date":"2029-06-26","underlying":"Common Stock","underlying_shares":4600},"source":{"system":"sec-edgar","filing":"0001104659-20-078794","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000110465920078794/a4.xml","form_type":"4"}},{"id":3096978,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-30T17:56:27.000Z","date":"2020-06-29","kind":"sale","acquired":false,"shares":4600,"price":116.8094,"value":537323.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This sale of common stock was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001104659-20-078794","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000110465920078794/a4.xml","form_type":"4"}},{"id":3096977,"issuer":{"id":664,"kind":"organization","name":"UNITED THERAPEUTICS Corp","symbol":"UTHR"},"owners":[{"id":77150,"kind":"person","name":"DWEK RAYMOND","position":1,"cik":"0001231617","reported_name":"DWEK RAYMOND","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-30T17:56:27.000Z","date":"2020-06-26","kind":"exercise","acquired":true,"shares":4600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares received upon vesting of restricted stock units on June 26, 2020. Restricted stock units converted on a one-for-one basis into shares of common stock."}],"balance_after":4600,"source":{"system":"sec-edgar","filing":"0001104659-20-078794","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1082554/000110465920078794/a4.xml","form_type":"4"}}],"next_cursor":"2020-06-30T17:56:27.000000Z,3096977"}